Logo image of JBTM

JBT MAREL CORP (JBTM) Stock Fundamental Analysis

USA - NYSE:JBTM - US4778391049 - Common Stock

136.27 USD
+1.26 (+0.93%)
Last: 9/18/2025, 12:07:11 PM
Fundamental Rating

3

Overall JBTM gets a fundamental rating of 3 out of 10. We evaluated JBTM against 128 industry peers in the Machinery industry. There are concerns on the financial health of JBTM while its profitability can be described as average. JBTM is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

JBTM had positive earnings in the past year.
JBTM had a positive operating cash flow in the past year.
Each year in the past 5 years JBTM has been profitable.
JBTM had a positive operating cash flow in each of the past 5 years.
JBTM Yearly Net Income VS EBIT VS OCF VS FCFJBTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

1.2 Ratios

JBTM's Return On Assets of -1.67% is on the low side compared to the rest of the industry. JBTM is outperformed by 74.22% of its industry peers.
The Return On Equity of JBTM (-3.15%) is worse than 71.88% of its industry peers.
Looking at the Return On Invested Capital, with a value of 1.16%, JBTM is doing worse than 71.09% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for JBTM is below the industry average of 10.02%.
The last Return On Invested Capital (1.16%) for JBTM is well below the 3 year average (5.49%), which needs to be investigated, but indicates that JBTM had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.67%
ROE -3.15%
ROIC 1.16%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
JBTM Yearly ROA, ROE, ROICJBTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

In the last couple of years the Profit Margin of JBTM has declined.
Looking at the Operating Margin, with a value of 3.46%, JBTM is doing worse than 66.41% of the companies in the same industry.
JBTM's Operating Margin has declined in the last couple of years.
The Gross Margin of JBTM (35.79%) is better than 65.63% of its industry peers.
JBTM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.46%
PM (TTM) N/A
GM 35.79%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
JBTM Yearly Profit, Operating, Gross MarginsJBTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so JBTM is destroying value.
Compared to 1 year ago, JBTM has about the same amount of shares outstanding.
Compared to 5 years ago, JBTM has more shares outstanding
JBTM has a worse debt/assets ratio than last year.
JBTM Yearly Shares OutstandingJBTM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
JBTM Yearly Total Debt VS Total AssetsJBTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.66, we must say that JBTM is in the distress zone and has some risk of bankruptcy.
JBTM has a Altman-Z score of 1.66. This is in the lower half of the industry: JBTM underperforms 71.88% of its industry peers.
The Debt to FCF ratio of JBTM is 6.79, which is on the high side as it means it would take JBTM, 6.79 years of fcf income to pay off all of its debts.
JBTM has a Debt to FCF ratio (6.79) which is in line with its industry peers.
JBTM has a Debt/Equity ratio of 0.44. This is a healthy value indicating a solid balance between debt and equity.
JBTM has a Debt to Equity ratio (0.44) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 6.79
Altman-Z 1.66
ROIC/WACC0.12
WACC9.42%
JBTM Yearly LT Debt VS Equity VS FCFJBTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

JBTM has a Current Ratio of 0.93. This is a bad value and indicates that JBTM is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.93, JBTM is not doing good in the industry: 89.06% of the companies in the same industry are doing better.
A Quick Ratio of 0.53 indicates that JBTM may have some problems paying its short term obligations.
JBTM's Quick ratio of 0.53 is on the low side compared to the rest of the industry. JBTM is outperformed by 89.84% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.53
JBTM Yearly Current Assets VS Current LiabilitesJBTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

6

3. Growth

3.1 Past

JBTM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.34%, which is quite impressive.
Measured over the past 5 years, JBTM shows a small growth in Earnings Per Share. The EPS has been growing by 0.52% on average per year.
The Revenue has grown by 64.98% in the past year. This is a very strong growth!
JBTM shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.48% yearly.
EPS 1Y (TTM)28.34%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%41.9%
Revenue 1Y (TTM)64.98%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%132.36%

3.2 Future

JBTM is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 22.22% yearly.
JBTM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.83% yearly.
EPS Next Y18.06%
EPS Next 2Y20.79%
EPS Next 3Y22.22%
EPS Next 5YN/A
Revenue Next Year113.26%
Revenue Next 2Y49.49%
Revenue Next 3Y32.93%
Revenue Next 5Y4.83%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
JBTM Yearly Revenue VS EstimatesJBTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
JBTM Yearly EPS VS EstimatesJBTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 24.08, JBTM is valued on the expensive side.
JBTM's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.20, JBTM is valued at the same level.
A Price/Forward Earnings ratio of 18.31 indicates a rather expensive valuation of JBTM.
Compared to the rest of the industry, the Price/Forward Earnings ratio of JBTM indicates a somewhat cheap valuation: JBTM is cheaper than 60.94% of the companies listed in the same industry.
JBTM is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.70, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.08
Fwd PE 18.31
JBTM Price Earnings VS Forward Price EarningsJBTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

JBTM's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. JBTM is more expensive than 75.00% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of JBTM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 25.03
EV/EBITDA 31.3
JBTM Per share dataJBTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
JBTM's earnings are expected to grow with 22.22% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.33
PEG (5Y)46.5
EPS Next 2Y20.79%
EPS Next 3Y22.22%

3

5. Dividend

5.1 Amount

JBTM has a yearly dividend return of 0.29%, which is pretty low.
JBTM's Dividend Yield is comparable with the industry average which is at 1.74.
With a Dividend Yield of 0.29, JBTM pays less dividend than the S&P500 average, which is at 2.38.
Industry RankSector Rank
Dividend Yield 0.29%

5.2 History

The dividend of JBTM has a limited annual growth rate of 0.48%.
JBTM has been paying a dividend for over 5 years, so it has already some track record.
JBTM has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.48%
Div Incr Years0
Div Non Decr Years4
JBTM Yearly Dividends per shareJBTM Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0 0 0 0 0

5.3 Sustainability

The earnings of JBTM are negative and hence is the payout ratio. JBTM will probably not be able to sustain this dividend level.
JBTM's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-12.49%
EPS Next 2Y20.79%
EPS Next 3Y22.22%
JBTM Yearly Income VS Free CF VS DividendJBTM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

JBT MAREL CORP

NYSE:JBTM (9/18/2025, 12:07:11 PM)

136.27

+1.26 (+0.93%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-04 2025-11-04/amc
Inst Owners87.99%
Inst Owner ChangeN/A
Ins Owners0.7%
Ins Owner Change4.08%
Market Cap7.08B
Analysts80
Price Target146.68 (7.64%)
Short Float %4.49%
Short Ratio4.57
Dividend
Industry RankSector Rank
Dividend Yield 0.29%
Yearly Dividend0.41
Dividend Growth(5Y)0.48%
DP-12.49%
Div Incr Years0
Div Non Decr Years4
Ex-Date08-18 2025-08-18 (0.1)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.06%
Min EPS beat(2)14.05%
Max EPS beat(2)14.08%
EPS beat(4)3
Avg EPS beat(4)6.06%
Min EPS beat(4)-8.58%
Max EPS beat(4)14.08%
EPS beat(8)5
Avg EPS beat(8)2.12%
EPS beat(12)9
Avg EPS beat(12)4.27%
EPS beat(16)10
Avg EPS beat(16)3.84%
Revenue beat(2)2
Avg Revenue beat(2)1.13%
Min Revenue beat(2)0.14%
Max Revenue beat(2)2.12%
Revenue beat(4)3
Avg Revenue beat(4)-0.85%
Min Revenue beat(4)-6.26%
Max Revenue beat(4)2.12%
Revenue beat(8)3
Avg Revenue beat(8)-2.8%
Revenue beat(12)3
Avg Revenue beat(12)-5.25%
Revenue beat(16)4
Avg Revenue beat(16)-4.6%
PT rev (1m)11.13%
PT rev (3m)14.86%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4.3%
EPS NY rev (1m)4.7%
EPS NY rev (3m)4.36%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)1.48%
Revenue NY rev (1m)1.42%
Revenue NY rev (3m)2%
Valuation
Industry RankSector Rank
PE 24.08
Fwd PE 18.31
P/S 2.61
P/FCF 25.03
P/OCF 20.93
P/B 1.62
P/tB N/A
EV/EBITDA 31.3
EPS(TTM)5.66
EY4.15%
EPS(NY)7.44
Fwd EY5.46%
FCF(TTM)5.44
FCFY3.99%
OCF(TTM)6.51
OCFY4.78%
SpS52.15
BVpS84.18
TBVpS-24.97
PEG (NY)1.33
PEG (5Y)46.5
Profitability
Industry RankSector Rank
ROA -1.67%
ROE -3.15%
ROCE 1.42%
ROIC 1.16%
ROICexc 1.18%
ROICexgc 6.59%
OM 3.46%
PM (TTM) N/A
GM 35.79%
FCFM 10.44%
ROA(3y)9.73%
ROA(5y)8.16%
ROE(3y)19.95%
ROE(5y)18.56%
ROIC(3y)5.49%
ROIC(5y)6.97%
ROICexc(3y)7.1%
ROICexc(5y)8.09%
ROICexgc(3y)24.27%
ROICexgc(5y)25.88%
ROCE(3y)6.33%
ROCE(5y)8.04%
ROICexcg growth 3Y-1.29%
ROICexcg growth 5Y-6.67%
ROICexc growth 3Y-5.85%
ROICexc growth 5Y-12.74%
OM growth 3Y-9.42%
OM growth 5Y-7.55%
PM growth 3Y-16.35%
PM growth 5Y-5.58%
GM growth 3Y1.99%
GM growth 5Y3.46%
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 6.79
Debt/EBITDA 6.81
Cap/Depr 29.44%
Cap/Sales 2.04%
Interest Coverage 250
Cash Conversion 119.97%
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.53
Altman-Z 1.66
F-Score3
WACC9.42%
ROIC/WACC0.12
Cap/Depr(3y)71.26%
Cap/Depr(5y)66.65%
Cap/Sales(3y)3.61%
Cap/Sales(5y)3.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)28.34%
EPS 3Y8.17%
EPS 5Y0.52%
EPS Q2Q%41.9%
EPS Next Y18.06%
EPS Next 2Y20.79%
EPS Next 3Y22.22%
EPS Next 5YN/A
Revenue 1Y (TTM)64.98%
Revenue growth 3Y7%
Revenue growth 5Y-2.48%
Sales Q2Q%132.36%
Revenue Next Year113.26%
Revenue Next 2Y49.49%
Revenue Next 3Y32.93%
Revenue Next 5Y4.83%
EBIT growth 1Y-41.04%
EBIT growth 3Y-3.08%
EBIT growth 5Y-9.84%
EBIT Next Year186.42%
EBIT Next 3Y57.26%
EBIT Next 5YN/A
FCF growth 1Y322.87%
FCF growth 3Y4%
FCF growth 5Y22.04%
OCF growth 1Y132.67%
OCF growth 3Y1.15%
OCF growth 5Y16.21%